Author

Hanifeh Mirtavoos‐Mahyari

Observed names: H. Mirtavoos-mahyari, Hanifeh Mirtavoos Mahyari, Hanifeh Mirtavoos-Mahyar, Hanifeh Mirtavoos-Mahyari, Hanifeh Mirtavoos-mahyari, Hanifeh Mirtavoos‐mahyari, Mirtavoos-Mahyari Hanifeh, میر طاووسی مهیاری, حنیفه
ORCID: 0000-0002-5604-8543
Observed ORCID: 0000-0002-5604-8543
OpenAlex ID: A5032003208
2019 · Keywan Mortezaee, Ensieh Salehi, et al. · Journal of Cellular Physiology · 357
2020 · Bagher Farhood, Ehsan khodamoradi, et al. · Pharmacological Research · 176
2018 · B. Farhood, N. H. Goradel, et al. · Clinical & Translational Oncology · 151
2019 · Keywan Mortezaee, Yaiza Potes, et al. · Life Sciences · 85
2019 · Keywan Mortezaee, Wrya Parwaie, et al. · International Immunopharmacology · 82
2018 · Peyman Amini, Hanifeh Mirtavoos-Mahyari, et al. · Current Molecular Pharmacology · 38
2019 · Bagher Farhood, Keywan Mortezaee, et al. · Journal of Cellular Biochemistry · 29
2019 · Hanifeh Mirtavoos‐Mahyari, Soudeh Ghafouri‐Fard, et al. · Clinical and Translational Medicine · 29
2019 · Zahra Azizi, Hanifeh Mirtavoos-Mahyari, et al. · Human Antibodies · 8
2020 · Amin Ardeshirdavani, Pooya Zakeri, et al. · medRxiv · 5
2014 · Hanifeh Mirtavoos Mahyari, Adnan Khosravi, et al. · Iranian Red Crescent Medical Journal · 5
2025 · Hamid Ahmadirad, Morteza Omrani, et al. · PLoS ONE · 4
2019 · Hanifeh Mirtavoos-Mahyari, Mohsen Ghadami, et al. · Asian Pacific Journal of Cancer Prevention · 3
2019 · Leila Farhady Tooli, Mahdieh Shirzad, et al. · World Journal of Microbiology and Biotechnology · 3
2025 · Hani Sabaie, Ali Taghavi Rad, et al. · Multiple Sclerosis and Related Disorders · 2
2014 · Mirtavoos-Mahyari Hanifeh, Adnan Khosravi, et al. · OncoTargets and Therapy · 2
Works count: 33
Citation count: 1,017
H-index: 9
I10-index: 9
Year
Topic
Type